Corpus Intelligence DCF — DANIEL DRAKE CENTER FOR POST-ACUTE C 2026-04-26 10:34 UTC
DCF — DANIEL DRAKE CENTER FOR POST-ACUTE C
Enterprise Value: $-34.5M
🛡️ Public data only — no PHI permitted on this instance.
$-34.5M
Enterprise Value
$-11.5M
PV of Cash Flows
$-22.9M
PV of Terminal Value
$-36.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth

Cash Flow Projections

PROJ
YearRevenueEBITDAMarginFCFPV(FCF)
Year 1$40.1M$-1.8M-4.0%$-3.5M$-3.2M
Year 2$41.3M$-1.4M-3.0%$-3.2M$-2.6M
Year 3$42.6M$-1.1M-2.0%$-2.9M$-2.2M
Year 4$43.8M$-0.9M-2.0%$-2.7M$-1.9M
Year 5$45.2M$-0.8M-2.0%$-2.7M$-1.7M

Interpretation

INT

At a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-34.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.

Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.

Assumptions

ASSM
revenue base$39.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999998973264527
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5